(Q52279689)

28 April 2018

title

The impact of naloxone/lofexidine combination treatment on the opiate withdrawal syndrome. (English)

1 reference

28 April 2018

author

John Strang

5

1 reference

28 April 2018

author name string

J. Bearn

1

1 reference

28 April 2018

J. Bennett

2

1 reference

28 April 2018

T. Martin

3

1 reference

28 April 2018

M. Gossop

4

1 reference

28 April 2018

publication date

1 April 2001

1 reference

28 April 2018

published in

Addiction Biology

1 reference

28 April 2018

volume

6

1 reference

28 April 2018

issue

2

1 reference

28 April 2018

page(s)

147-156

1 reference

28 April 2018

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Under siege: The brain on opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Clonidine and the treatment of the opiate withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Forced opiate withdrawal under anaesthesia augments and prolongs the occurrence of withdrawal signs in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Opioid detoxification using naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Type of hospital setting and treatment outcome with heroin addicts. Results from a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

A review of biological indicators of illicit drug use, practical considerations and clinical usefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Clinical Utility of Rapid Clonidine-naltrcxone Detoxification for Opioid Abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Rapid opioid detoxification using opioid antagonists: history, theory and the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

Is there a pharmacological basis for therapy with rapid opioid detoxification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

The efficacy of naltrexone in preventing reabuse of heroin after detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210020040226

10.1080/13556210020040226

21 January 2018

Identifiers

DOI

1 reference

28 April 2018

1 reference

28 April 2018